How can ophthalmologists better educate patients about the severity of DME progression?
Early detection and treatment of DR and DME are essential
APAO 2023: Step therapy from Bevacizumab to Aflibercept for DME
4D Molecular Therapeutics: FDA clears IND application for 4D-150 genetic medicine to treat DME
Study: More than a quarter of older Americans have visual impairment
Rezolute announces initiation of a phase 2 study of RZ402 in patients with diabetic macular edema
2023: What awaits ophthalmology in the year ahead
2 Clarke Drive Cranbury, NJ 08512